Downstream Processing Featured Articles

41. Scientists Find A New Way To Boost Common Cancer Drugs 1/14/2013

    Shutting down a specific pathway in cancer cells appears to improve the ability of common drugs to wipe those cells out, according to new research from scientists at Fox Chase Cancer Center, published in the January issue of Cancer Discovery.

42. Pittcon 2013 Conference Tackles Life Sciences Challenges, Novel Research 2/7/2013

    Pittcon has always been the premiere venue for companies to launch new products and for scientists to present their latest research to a global audience.

43. A Class Of RNA Molecules Protects Germ Cells From Damage, Penn Vet Researchers Show 11/15/2012

    Passing one’s genes on to the next generation is a mark of evolutionary success. So it makes sense that the body would work to ensure that the genes the next generation inherits are exact replicas of the originals.

44. Additional Details Concerning Issue Of Shares To Johnson & Johnson Development Corporation As Part Of The Daratumumab Agreement 8/30/2012

    Genmab A/S announced recently additional details concerning the subscription of shares by Johnson & Johnson Development Corporation (JJDC) as part of the global license and development agreement for daratumumab (HuMax-CD38) between Genmab (see Genmab's Company Announcement 20) and Janssen Biotech, Inc., one of the Janssen Pharmaceutical companies of Johnson & Johnson.

45. Stainless Steel Vial Filling System Developed For Use In Vaccine Facilities 7/17/2014

    TAP Biosystems (now part of the Sartorius Stedim Biotech Group), a leading supplier of innovative cell culture and fermentation systems for life science applications, recently announced the development of a stainless steel version of the fill-it system, designed for safely dispensing biohazardous materials such as vaccine stocks.

46. Cancer Research UK And Lorus To Co-Develop First-Of-Kind Drug, IL-17E, To Treat Solid Tumours 11/27/2012

    CANCER RESEARCH UK'S Drug Development Office; Cancer Research Technology, the charity's commercial arm; and biopharmaceutical company, Lorus Therapeutics Inc. (Lorus) (TSX:LOR), have partnered to take a new therapy with the potential to treat solid tumours, into its first clinical trial.

47. Making The Switch To Single-Use: Have You Thought Of Everything? 8/19/2015

    In 2014, Prolong Pharmaceuticals followed through with a decision to build a facility for the scale-up of their lead product, SANGUINATE. As part of this decision, the new facility would not utilize Prolong’s traditional manufacturing process and would instead switch to one that uses single-use technology (SUT) almost exclusively. Chuck Hart, Prolong’s director of manufacturing, recently sat down with me to discuss some areas he feels are sometimes overlooked when switching from traditional stainless steel to SUT.

48. Genetic Markers ID Second Alzheimer's Pathway 4/4/2013

    Researchers at Washington University School of Medicine in St. Louis have identified a new set of genetic markers for Alzheimer’s that points to a second pathway through which the disease develops. By Jim Dryden

49. Caliper's 'Lab On A Chip' Technology To Screen Neurocrine Assays 1/21/1999
    Caliper Technologies Corp. and Neurocrine Biosciences, Inc. are combining their drug discovery efforts to develop treatments for central nervous system and immune system diseases...
50. Breast Cancer Clinical Trial To Test Combination Of Heat Shock Protein Inhibitor And Hormonal Therapy 5/22/2012

    Pushed to the brink of survival, the hyper-driven cells of a cancerous tumor tap into an ancient system that has helped organisms cope with internal stresses and environmental challenges since life began. By Nicole Giese Rura